サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：体外受精市場-世界の産業規模、シェア、動向、機会、予測、2018-2028年
市場調査レポート
商品コード
1326505

体外受精市場-世界の産業規模、シェア、動向、機会、予測、2018-2028年

In-Vitro Fertilization Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Technique, By Product, By Egg Donor, By Infertility, By Infertility, By Region and Competition
出版日: | 発行: TechSci Research | ページ情報: 英文 117 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

体外受精市場-世界の産業規模、シェア、動向、機会、予測、2018-2028年
出版日: 2023年08月01日
発行: TechSci Research
ページ情報: 英文 117 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

体外受精市場は、2024年から2028年の予測期間中に目覚ましい成長を遂げると思われます。

この成長の背景には、不妊率の上昇、体外受精技術の進歩、出産を遅らせる傾向の高まりがあります。

不妊率の上昇

不妊率の上昇は、予測期間における体外受精（IVF）市場の主要促進要因の1つです。不妊症は、ライフスタイルの変化、出産の遅れ、多嚢胞性卵巣症候群（PCOS）などの罹患率の増加など、さまざまな要因によって世界的に蔓延しつつあります。その結果、不妊症の解決策として体外受精の需要が高まっており、体外受精市場の成長を牽引するものと期待されています。

不妊率が上昇を続ける中、不妊問題の解決策として体外受精を利用する人が増えています。体外受精は、長い間妊娠を試みているが成功しないカップルや、自然妊娠を妨げる他の疾患があるカップルにとって特に有用です。

体外受精サービスに対する需要の高まりが、予測期間における体外受精市場の成長を牽引すると予想されます。この成長は、体外受精サービスへのアクセスが限られているが不妊治療のニーズが高い新興諸国において特に顕著になると予想されます。このような国々では、体外受精の利点がより多くの人々に認識されるようになり、ヘルスケアシステムがより高度化するにつれて、体外受精サービスの市場は成長すると予想されます。

さらに、技術の進歩により、体外受精はより身近で手頃なものとなっています。例えば、胚培養、凍結保存、実験室技術の向上はすべて、成功率の向上とコストの低減に貢献し、体外受精をより多くの人々が利用しやすくしています。これにより、体外受精サービスに対する需要がさらに高まり、予測期間中の体外受精市場の成長を牽引すると予想されます。

不妊率の上昇は、予測期間における体外受精の世界市場の主要な促進要因になると予想されます。不妊に悩む人が増えるにつれ、特に不妊治療へのアクセスが制限されている発展途上国では、体外受精サービスへの需要が増加すると予想されます。

体外受精技術の進歩

体外受精の需要は、体外受精技術の進歩の結果として増加しています。1978年に体外受精による最初の出産が実現して以来、多くのことが達成されてきました。今日、体外受精は、複数のステップと高度な技術を伴う高度に洗練された方法です。

体外受精技術における最も重要な進歩のひとつは、着床前遺伝学的検査（PGT）です。PGTによって、胚は子宮に移植される前に遺伝的障害をスクリーニングされます。PGTは体外受精の成功率を向上させ、子孫の遺伝的障害のリスクを減らすことができます。

体外受精技術のもう一つの進歩は、タイムラプス画像の使用です。タイムラプス画像は、胚培養士がリアルタイムで胚の発達を監視し、それらの生存率と品質に関するより詳細な情報を提供することができます。

これらの進歩に加えて、体外受精クリニックは現在、卵子凍結、精子バンク、代理出産を含む様々なサービスを提供しています。これらのサービスは、不妊に悩むカップルに多くの選択肢を提供し、体外受精市場の成長に貢献しています。

出産遅延へのシフト

出産遅延へのシフトも、予測期間における体外受精（IVF）世界市場成長の要因です。社会的・経済的要因の変化に伴い、人々は人生の後半まで子供を産むのを遅らせることを選択するようになっています。このような出産の遅れは、卵巣予備能の低下や子宮内膜症のような疾患の罹患率の増加など、加齢に関連した要因による不妊症リスクの増加と関連しています。

子供を持つことを遅らせることを選択する人が増えるにつれ、体外受精サービスの需要は増加すると予想されます。体外受精は、年齢的要因による不妊に悩むカップルにとって現実的な選択肢となっています。体外受精は、卵巣予備能が低下していても、自分の卵子を使って妊娠することができます。つまり、自然妊娠可能期間を過ぎた女性でも妊娠できるのです。

さらに、胚培養や凍結保存技術の向上など、体外受精の技術が進歩したことで、体外受精による妊娠が成功する確率が高まりました。このような進歩により、体外受精の成功率は高まり、費用も安くなったため、妊娠を希望するカップルにとって、体外受精はより身近で手の届くものとなっています。

出産を遅らせる方向へのシフトが、予測期間における体外受精市場の成長を牽引すると予想されます。この成長は、出産遅延の動向が最も顕著な新興諸国において特に顕著になると予想されます。これらの国々では、年齢的要因による不妊に悩む夫婦にとって、体外受精治療はますますポピュラーな選択肢となっています。

出産遅延へのシフトは、予測期間における体外受精の世界市場の主要な促進要因になると予想されます。出産を遅らせる人が増えるにつれて、体外受精サービスの需要は、特にその動向が顕著な先進諸国で増加すると予想されます。

利用可能なカスタマイズ

TechSci Researchでは、所定の市場データを使用して、企業固有のニーズに応じたカスタマイズを提供しています。レポートでは以下のカスタマイズが可能です：

企業情報

  • 追加市場参入企業（最大5社）の詳細分析とプロファイリング

目次

第1章 サービス概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 体外受精の世界市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 技術別
    • 製品別
    • 卵子ドナー別
    • 不妊症別
    • 用途別
    • 地域別
    • 企業別
  • 製品マップ

第6章 北米の体外受精市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 技術別
    • 製品別
    • 卵子ドナー別
    • 不妊症別
    • 用途別
    • 国別
  • 北米：国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州の体外受精市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 技術別
    • 製品別
    • 卵子ドナー別
    • 不妊症別
    • 用途別
    • 国別
  • 欧州国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋地域の体外受精市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 技術別
    • 製品別
    • 卵子ドナー別
    • 不妊症別
    • 用途別
    • 国別
  • アジア太平洋：国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第9章 南米の体外受精市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 技術別
    • 製品別
    • 卵子ドナー別
    • 不妊症別
    • 用途別
    • 国別
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカの体外受精市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 技術別
    • 製品別
    • 卵子ドナー別
    • 不妊症別
    • 用途別
    • 国別
  • MEA：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • トルコ

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の展開
  • 合併・買収
  • 製品発表

第13章 体外受精の世界市場SWOT分析

第14章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第15章 競合情勢

  • Business Overview
  • Service Offerings
  • Recent Developments
  • Key Personnel
    • The Fertility Center of Las Vegas
    • Overlake Reproductive Health
    • Gennet City Fertility
    • Zita West Clinic
    • Fertility Plus Clinic
    • Nova IVF Centre and Fertility Clinic
    • Bloom IVF Centre
    • Progenesis Fertility Center
    • Medicana IVF Center
    • Medical Park Hospitals
    • ART Fertility Clinics
    • Millennium Medical Center（MMC）IVF Fertility Center
    • Tambre Fertility Clinic
    • Medical Park Hospitals
    • Hisar Hospital

第16章 戦略的提言

目次
Product Code: 15131

In-Vitro Fertilization Market will see impressive growth during the forecast period, 2024-2028. This growth is accounted for by increasing infertility rates, advancements in IVF technology, and a growing trend toward delaying childbirth.

In-vitro fertilization (IVF) is a medical procedure that involves fertilizing an egg with sperm outside the body in a laboratory dish and then transferring the embryo to the uterus. It is a widely used assisted reproductive technology (ART) that has helped millions of couples worldwide to conceive.

The infertility rate has been increasing globally. This is one of the key factors driving the growth of the IVF market. Several factors, including lifestyle changes, pollution, and an increase in age-related infertility, have contributed to the rising infertility rates.

Technological advancements in IVF have made the procedure safer, more effective, and less invasive. The use of preimplantation genetic testing (PGT) to screen embryos for genetic abnormalities, for example, has increased the success rates of IVF and reduced the risk of genetic disorders.

Medical tourism has emerged as a key driver of the IVF market in recent years. Patients from countries where IVF treatment is either expensive or unavailable are increasingly traveling to other countries to undergo treatment. This has helped to boost demand for IVF in countries with advanced IVF infrastructure and expertise.

The growing trend of fertility preservation, particularly among cancer patients, is driving demand for IVF services. As more people seek to preserve their fertility before undergoing treatments that could potentially harm their reproductive capacity, in such cases, IVF is becoming an increasingly important option.

A growing trend towards delaying childbirth has contributed to the growth of the IVF market. Women are now focusing on their careers and delaying pregnancy until later in life. This has led to a higher demand for IVF services, as women over the age of 35 are more likely to experience infertility.

However, with any rapidly growing industry, the IVF market faces challenges that could impact its long-term sustainability and success. One of the primary challenges the IVF market is facing is the cost of treatment. IVF is an expensive procedure, and even in countries with universal healthcare, access to IVF is often limited to those who can afford it. This has led to concerns about the affordability of IVF, particularly as demand for the treatment continues to rise.

Another challenge being faced by the IVF market is the ethical and moral considerations associated with the procedure. There are concerns that IVF could be used to create designer babies or that embryos may be discarded or used for research purposes without consent. As a result, there is a need for clear guidelines and regulations to ensure that IVF is used ethically and responsibly.

The procedure's high rate of multiple births will also impede market expansion in the coming years. To improve the probability of success, IVF frequently involves the transfer of numerous embryos, but this can lead to multiple pregnancies, which are linked to a higher risk of issues like early birth and low birth weight. To lower the probability of multiple births, more efficient embryo selection techniques are required.

Rising Infertility Rates

Rising infertility rates are one of the key drivers of the market for in-vitro fertilization (IVF) in the forecast period. Infertility is becoming more prevalent worldwide due to a range of factors, including changing lifestyles, delayed childbearing, and increasing incidence of conditions such as polycystic ovary syndrome (PCOS). As a result, there is a growing demand for IVF as a solution to infertility, which is expected to drive growth in the IVF market.

As infertility rates continue to rise, more people are turning to IVF as a solution to their fertility problems. IVF is particularly useful for couples who have been trying to conceive for a long time without success or who have other medical conditions that prevent them from conceiving naturally.

The rising demand for IVF services is expected to drive growth in the IVF market in the forecast period. This growth is expected to be particularly strong in developing countries, where access to IVF services is limited, but the need for infertility treatments is high. In these countries, the market for IVF services is expected to grow as more people become aware of the benefits of IVF and as healthcare systems become more advanced.

Furthermore, advancements in technology have made IVF more accessible and affordable. For example, improvements in embryo culture, cryopreservation, and laboratory techniques have all contributed to higher success rates and lower costs, making IVF more accessible to a wider population. This has further increased the demand for IVF services and is expected to drive the growth of the IVF Market in the forecast period.

Rising infertility rates are expected to be a key driver of the global market for in-vitro fertilization in the forecast period. As more people struggle with infertility, the demand for IVF services is expected to increase, particularly in developing countries where access to infertility treatments is limited.

Advancements in IVF Technology

IVF demand has increased as an outcome of advancements in IVF technology. Since the first birth made possible by IVF in 1978, much has been accomplished. Today, IVF is a highly sophisticated procedure that involves multiple steps and advanced technologies.

One of the most significant advances in IVF technology is Preimplantation Genetic Testing (PGT). PGT allows embryos to be screened for genetic disorders before they are implanted into the uterus. PGT can improve the success rates of IVF and reduce the risk of genetic disorders in offspring.

Another advancement in IVF technology is the use of time-lapse imaging. Time-lapse imaging allows embryologists to monitor the development of embryos in real time, providing more detailed information about their viability and quality.

In addition to these advances, IVF clinics are now offering a range of services, including egg freezing, sperm banking, and surrogacy. These services provide more options for couples struggling with infertility and have contributed to the growth of the IVF market.

Shift Towards Delayed Childbirth

The shift towards delayed childbirth is another factor responsible for the growth of the global market of in-vitro fertilization (IVF) in the forecast period. With changing social and economic factors, people are choosing to delay having children until later in life. This delay in childbearing has been associated with an increased risk of infertility due to age-related factors, such as decreased ovarian reserve and an increased incidence of conditions like endometriosis.

As more people choose to delay having children, the demand for IVF services is expected to increase. IVF has become a viable option for couples who are struggling with infertility due to age-related factors. IVF treatment can help women to conceive using their own eggs, even if their ovarian reserve has declined. This means that women who are past their natural fertility window can conceive.

Moreover, the advancements in IVF technology, including improved embryo culture and cryopreservation techniques, have increased the chances of successful conception using IVF treatment. These advancements have resulted in higher success rates and lower costs, making IVF more accessible and affordable for couples who are looking to conceive.

The shift towards delayed childbirth is expected to drive the growth of the IVF market in the forecast period. This growth is expected to be particularly strong in developing countries, where the trend towards delayed childbirth is most pronounced. In these countries, IVF treatment has become an increasingly popular option for couples who are struggling with infertility due to age-related factors.

The shift towards delayed childbirth is expected to be a key driver of the global market for in vitro fertilization in the forecast period. As more people delay having children, the demand for IVF services is expected to increase, particularly in developed countries where the trend is most pronounced.

Market Segmentation

Global In-Vitro Fertilization Market can be segmented based on technique, product, egg donor, infertility, application, and region. Based on technique, the market can be divided into ICSI IVF and non-ICSI/ traditional IVF. Based on product, the market is divided into IVF culture media, ICSI machines, IVF incubators, cryo-system, and others. Based on egg donors, the market is divided into frozen non-donor, fresh non-donor, frozen donors, and fresh donors. Based on infertility, the market can be divided into male and female. Based on application, the market is divided into fertility clinics, hospitals, and others. Regionally, the In-Vitro Fertilization Market can be categorized into North America, Europe, Asia Pacific, South America, and Middle East & Africa.

Market Players

The Fertility Center of Las Vegas, Overlake Reproductive Health, Gennet City Fertility, Zita West Clinic, Fertility Plus Clinic, Nova IVF Centre and Fertility Clinic, Bloom IVF Centre, Progenesis Fertility Center, Medicana IVF Center, Medical Park Hospitals, ART Fertility Clinics, Millennium Medical Center (MMC) IVF Fertility Center, Tambre Fertility Clinic, Medical Park Hospitals, Hisar Hospital among others are the leading players operating in the Global In-Vitro Fertilization Market.

Report Scope:

In this report, Global In-Vitro Fertilization Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

In-Vitro Fertilization Market, By Technique:

  • ICSI IVF
  • Non-ICSI/ Traditional IVF

In-Vitro Fertilization Market, By Product:

  • IVF Culture Media
  • ICSI Machine
  • IVF Incubators
  • Cryo-System
  • Others

In-Vitro Fertilization Market, By Egg Donor:

  • Frozen Non-donor
  • Fresh Non-donor
  • Frozen Donor
  • Fresh Donor

In-Vitro Fertilization Market, By Infertility:

  • Male
  • Female

In-Vitro Fertilization Market, By Application:

  • Fertility Clinics
  • Hospitals
  • Others

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global In-Vitro Fertilization Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Service Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global In-Vitro Fertilization Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technique (ICSI IVF v/s Non-ICSI/ Traditional IVF)
    • 5.2.2. By Product (IVF Culture Media, ICSI Machine, IVF Incubators, Cryo-System, Others)
    • 5.2.3. By Egg Donor (Frozen Non-donor, Fresh Non-donor, Frozen Donor, Fresh Donor)
    • 5.2.4. By Infertility (Male v/s Female)
    • 5.2.5. By Application (Fertility Clinics, Hospitals, Others)
    • 5.2.6. By Region
    • 5.2.7. By Company (2022)
  • 5.3. Product Map

6. North America In-Vitro Fertilization Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technique
    • 6.2.2. By Product
    • 6.2.3. By Egg Donor
    • 6.2.4. By Infertility
    • 6.2.5. By Application
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States In-Vitro Fertilization Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Technique
        • 6.3.1.2.2. By Product
        • 6.3.1.2.3. By Egg Donor
        • 6.3.1.2.4. By Infertility
        • 6.3.1.2.5. By Application
    • 6.3.2. Canada In-Vitro Fertilization Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Technique
        • 6.3.2.2.2. By Product
        • 6.3.2.2.3. By Egg Donor
        • 6.3.2.2.4. By Infertility
        • 6.3.2.2.5. By Application
    • 6.3.3. Mexico In-Vitro Fertilization Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Technique
        • 6.3.3.2.2. By Product
        • 6.3.3.2.3. By Egg Donor
        • 6.3.3.2.4. By Infertility
        • 6.3.3.2.5. By Application

7. Europe In-Vitro Fertilization Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technique
    • 7.2.2. By Product
    • 7.2.3. By Egg Donor
    • 7.2.4. By Infertility
    • 7.2.5. By Application
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France In-Vitro Fertilization Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technique
        • 7.3.1.2.2. By Product
        • 7.3.1.2.3. By Egg Donor
        • 7.3.1.2.4. By Infertility
        • 7.3.1.2.5. By Application
    • 7.3.2. Germany In-Vitro Fertilization Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technique
        • 7.3.2.2.2. By Product
        • 7.3.2.2.3. By Egg Donor
        • 7.3.2.2.4. By Infertility
        • 7.3.2.2.5. By Application
    • 7.3.3. United Kingdom In-Vitro Fertilization Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Technique
        • 7.3.3.2.2. By Product
        • 7.3.3.2.3. By Egg Donor
        • 7.3.3.2.4. By Infertility
        • 7.3.3.2.5. By Application
    • 7.3.4. Italy In-Vitro Fertilization Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technique
        • 7.3.4.2.2. By Product
        • 7.3.4.2.3. By Egg Donor
        • 7.3.4.2.4. By Infertility
        • 7.3.4.2.5. By Application
    • 7.3.5. Spain In-Vitro Fertilization Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technique
        • 7.3.5.2.2. By Product
        • 7.3.5.2.3. By Egg Donor
        • 7.3.5.2.4. By Infertility
        • 7.3.5.2.5. By Application

8. Asia-Pacific In-Vitro Fertilization Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technique
    • 8.2.2. By Product
    • 8.2.3. By Egg Donor
    • 8.2.4. By Infertility
    • 8.2.5. By Application
    • 8.2.6. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China In-Vitro Fertilization Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technique
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By Egg Donor
        • 8.3.1.2.4. By Infertility
        • 8.3.1.2.5. By Application
    • 8.3.2. India In-Vitro Fertilization Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technique
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By Egg Donor
        • 8.3.2.2.4. By Infertility
        • 8.3.2.2.5. By Application
    • 8.3.3. Japan In-Vitro Fertilization Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technique
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By Egg Donor
        • 8.3.3.2.4. By Infertility
        • 8.3.3.2.5. By Application
    • 8.3.4. South Korea In-Vitro Fertilization Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technique
        • 8.3.4.2.2. By Product
        • 8.3.4.2.3. By Egg Donor
        • 8.3.4.2.4. By Infertility
        • 8.3.4.2.5. By Application
    • 8.3.5. Australia In-Vitro Fertilization Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technique
        • 8.3.5.2.2. By Product
        • 8.3.5.2.3. By Egg Donor
        • 8.3.5.2.4. By Infertility
        • 8.3.5.2.5. By Application

9. South America In-Vitro Fertilization Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technique
    • 9.2.2. By Product
    • 9.2.3. By Egg Donor
    • 9.2.4. By Infertility
    • 9.2.5. By Application
    • 9.2.6. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil In-Vitro Fertilization Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technique
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By Egg Donor
        • 9.3.1.2.4. By Infertility
        • 9.3.1.2.5. By Application
    • 9.3.2. Argentina In-Vitro Fertilization Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technique
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By Egg Donor
        • 9.3.2.2.4. By Infertility
        • 9.3.2.2.5. By Application
    • 9.3.3. Colombia In-Vitro Fertilization Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technique
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By Egg Donor
        • 9.3.3.2.4. By Infertility
        • 9.3.3.2.5. By Application

10. Middle East and Africa In-Vitro Fertilization Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technique
    • 10.2.2. By Product
    • 10.2.3. By Egg Donor
    • 10.2.4. By Infertility
    • 10.2.5. By Application
    • 10.2.6. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa In-Vitro Fertilization Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technique
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By Egg Donor
        • 10.3.1.2.4. By Infertility
        • 10.3.1.2.5. By Application
    • 10.3.2. Saudi Arabia In-Vitro Fertilization Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technique
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By Egg Donor
        • 10.3.2.2.4. By Infertility
        • 10.3.2.2.5. By Application
    • 10.3.3. UAE In-Vitro Fertilization Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technique
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By Egg Donor
        • 10.3.3.2.4. By Infertility
        • 10.3.3.2.5. By Application
    • 10.3.4. Turkey In-Vitro Fertilization Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Technique
        • 10.3.4.2.2. By Product
        • 10.3.4.2.3. By Egg Donor
        • 10.3.4.2.4. By Infertility
        • 10.3.4.2.5. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global In-Vitro Fertilization Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Service Offerings
  • 15.3. Recent Developments
  • 15.4. Key Personnel
    • 15.4.1. The Fertility Center of Las Vegas
    • 15.4.2. Overlake Reproductive Health
    • 15.4.3. Gennet City Fertility
    • 15.4.4. Zita West Clinic
    • 15.4.5. Fertility Plus Clinic
    • 15.4.6. Nova IVF Centre and Fertility Clinic
    • 15.4.7. Bloom IVF Centre
    • 15.4.8. Progenesis Fertility Center
    • 15.4.9. Medicana IVF Center
    • 15.4.10. Medical Park Hospitals
    • 15.4.11. ART Fertility Clinics
    • 15.4.12. Millennium Medical Center (MMC) IVF Fertility Center
    • 15.4.13. Tambre Fertility Clinic
    • 15.4.14. Medical Park Hospitals
    • 15.4.15. Hisar Hospital

16. Strategic Recommendations